These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 102751)

  • 1. A patient with nucleoside phosphorylase deficiency, selective t-cell deficiency, and autoimmune hemolytic anemia.
    Carapella-de Luca E; Aiuti F; Lucarelli P; Bruni L; Baroni CD; Imperato C; Roos D; Astaldi A
    J Pediatr; 1978 Dec; 93(6):1000-3. PubMed ID: 102751
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular immune deficiency with autoimmune hemolytic anemia in purine nucleoside phosphorylase deficiency.
    Rich KC; Arnold WJ; Palella T; Fox IH
    Am J Med; 1979 Jul; 67(1):172-6. PubMed ID: 111549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purine nucleoside phosphorylase deficiency associated with a fatal lymphoproliferative disorder.
    Watson AR; Evans DI; Marsden HB; Miller V; Rogers PA
    Arch Dis Child; 1981 Jul; 56(7):563-5. PubMed ID: 6791594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purine nucleoside phosphorylase deficiency: a molecular model for selective loss of T cell function.
    Ochs UH; Chen SH; Ochs HD; Osborne WR; Scott CR
    J Immunol; 1979 Jun; 122(6):2424-9. PubMed ID: 109531
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological aberrations in purine nucleoside phosphorylase deficiencies.
    Ammann AJ
    Ciba Found Symp; 1978; (68):55-75. PubMed ID: 159164
    [No Abstract]   [Full Text] [Related]  

  • 6. Phosphorylation of deoxyguanosine by B and T lymphocytes: evidence against selective trapping of deoxyguanosine by T lymphocytes in purine nucleoside phosphorylase deficiency.
    North ME; Newton CA; Webster AD
    Clin Exp Immunol; 1980 Dec; 42(3):523-9. PubMed ID: 6783354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purine nucleoside phosphorylase (PNP) deficiency: a therapeutic challenge.
    Watson AR; Simmonds HA; Webster DR; Layward L; Evans DI
    Adv Exp Med Biol; 1984; 165 Pt A():53-9. PubMed ID: 6426259
    [No Abstract]   [Full Text] [Related]  

  • 8. Purine nucleoside phosphorylase deficiency associated with selective cellular immunodeficiency.
    Stoop JW; Zegers BJ; Hendrickx GF; van Heukelom LH; Staal GE; de Bree PK; Wadman SK; Ballieux RE
    N Engl J Med; 1977 Mar; 296(12):651-5. PubMed ID: 402573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine deaminase (ADA) and other enzyme abnormalities in immune deficiency states.
    Goldblum RM; Schmalstieg FC; Nelson JA; Mills GC
    Birth Defects Orig Artic Ser; 1978; 14(6A):73-84. PubMed ID: 215243
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary purines in a patient with a severely defective T cell immunity and a purine nucleoside phosphorylase deficiency.
    Wadman SK; de Bree PK; van Gennip AH; Stoop JW; Zegers BJ; Staal GE; Siegenbeek LH
    Adv Exp Med Biol; 1977; 76A():471-6. PubMed ID: 404853
    [No Abstract]   [Full Text] [Related]  

  • 11. [Primary immunodeficiencies and purine metabolism].
    Romo Cortina A; Lorente Toledano F; Salazar Villalobos V
    Rev Clin Esp; 1985 Oct; 177(6):247-53. PubMed ID: 3001848
    [No Abstract]   [Full Text] [Related]  

  • 12. Partial deficiency of purine nucleoside phosphorylase: studies of purine and pyrimidine metabolism.
    Edwards NL; Gelfand EW; Biggar D; Fox IH
    J Lab Clin Med; 1978 May; 91(5):736-49. PubMed ID: 417142
    [No Abstract]   [Full Text] [Related]  

  • 13. B cell hyperactivity and abnormalities in T cell markers and immunoregulatory function in a patient with nucleoside phosphorylase deficiency.
    Zabay JM; De La Concha EG; Ludeña C; Lozano C; Pascual-Salcedo D; Bootello A; Gonzalezporqué P
    Clin Exp Immunol; 1982 Dec; 50(3):610-6. PubMed ID: 6819909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy and immunopathologic studies in a patient with nucleoside phosphorylase deficiency.
    Ammann AJ; Wara DW; Allen T
    Clin Immunol Immunopathol; 1978 Jul; 10(3):262-9. PubMed ID: 97038
    [No Abstract]   [Full Text] [Related]  

  • 15. An approach to the restoration of T cell function in a purine nucleoside phosphorylase deficient patient.
    Zegers BJ; Stoop JW; Staal GE; Wadman SK
    Ciba Found Symp; 1978; (68):231-53. PubMed ID: 115663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical basis for lymphocyte dysfunction in adenosine deaminase and purine nucleoside phosphorylase deficiencies.
    Carson DA; Wasson DB; Lakow E; Kamatani N
    Adv Exp Med Biol; 1984; 165 Pt B():133-9. PubMed ID: 6426261
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemistry of diseases of immunodevelopment.
    Martin DW; Gelfand EW
    Annu Rev Biochem; 1981; 50():845-77. PubMed ID: 6267992
    [No Abstract]   [Full Text] [Related]  

  • 18. A second case of inosine phosphorylase deficiency with severe T-cell abnormalities.
    Hamet M; Griscelli C; Cartier P; Ballay J; de Bruyn C; Hösli P
    Adv Exp Med Biol; 1977; 76A():477-80. PubMed ID: 404854
    [No Abstract]   [Full Text] [Related]  

  • 19. Deoxyguanosine toxicity in a mouse T lymphoma: relationship to purine nucleoside phosphorylase-associated immune dysfunction.
    Gudas LJ; Ullman B; Cohen A; Martin DW
    Cell; 1978 Jul; 14(3):531-8. PubMed ID: 99243
    [No Abstract]   [Full Text] [Related]  

  • 20. Purine nucleoside phosphorylase deficiency: improved metabolic and immunologic function with erythrocyte transfusions.
    Rich KC; Majias E; Fox IH
    N Engl J Med; 1980 Oct; 303(17):973-7. PubMed ID: 6774252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.